Description

Dicynone (Etamsilat) Solution for Injections Ampoules 250 mg. 2 ml. №50

Ingredients:

Dicynone (Etamsilat) solution for injections contains 250 mg of etamsilat in a 2 ml ampoule.

Dosage:

The recommended dosage of Dicynone solution for injections is determined by a healthcare provider based on the individual’s condition. It is typically administered intramuscularly or intravenously.

Indications:

Dicynone solution for injections is indicated for the treatment of various bleeding disorders, including capillary and small vessel bleeding, menorrhagia, and bleeding complications during surgery.

Contraindications:

Do not use Dicynone solution for injections if you are allergic to etamsilat or any other ingredients in the formulation. It is also contraindicated in patients with a history of thromboembolic events.

Directions:

Follow the instructions provided by your healthcare provider for the correct administration of Dicynone solution for injections. Do not self-administer without proper medical guidance.

Scientific Evidence:

Studies have shown that etamsilat, the active ingredient in Dicynone solution for injections, effectively reduces bleeding time and promotes hemostasis in various clinical settings. Research has demonstrated its efficacy in managing bleeding disorders and improving patient outcomes.

Additional Information:

• Storage: Store Dicynone solution for injections as per the instructions to maintain its stability and efficacy.
• Side Effects: Common side effects may include nausea, vomiting, or allergic reactions. Consult your doctor if any adverse reactions occur.

Pharmacological Effects: Etamsilat works by enhancing platelet adhesiveness and capillary resistance, leading to improved hemostasis and reduced bleeding time. It also exhibits anti-inflammatory properties, contributing to its effectiveness in managing bleeding disorders.

Clinical Trials: Clinical trials have demonstrated the efficacy of Dicynone solution for injections in reducing bleeding episodes and improving hemostasis in patients with various bleeding disorders. Comparative studies have shown favorable outcomes compared to traditional treatment modalities.